11 October 2017 EMA/764352/2017 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance(s): amlodipine

Procedure No.: PSUSA/00000174/201703

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Product name in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Amlobesilat-Sandoz® 10 mg Tabletten Amlodipin – 1 A Pharma 7,5 mg Tabletten N Amlodipin "1A Farma", tabletter Amlodipin "Sandoz", tabletter Amlodipin 1A Pharma 7,5 mg - Tabletten Amlodipin Hexal 7,5 mg Tabletten Amlodipin HEXAL 7,5 mg Tabletten Amlodipin Sandoz 7,5 mg – Tabletten Amlodipina Pfizer Italia 10 mg compresse Amlodipina Pfizer Italia 5 mg compresse Amlodipine 10 mg Tablets Amlodipine 10 mg tablets Amlodipine 5 mg Tablets Amlodipine 5 mg tablets Amlodipine Pfizer 10 mg Tablets AMLODIPINE PFIZER 10 mg, gélule AMLODIPINE PFIZER 10 mg, gélule AMLODIPINE PFIZER 10 mg, gélule Amlodipine Pfizer 5 mg Tablets AMLODIPINE PFIZER 5 mg, gélule

DK/H/0964/002

66353.00.00

HEXAL AG

DE

DK/H/0963/002

66350.00.00

1 A PHARMA GMBH

DE

DK/H/0963/002

36551

1A FARMA A/S

DK

DK/H/0964/002

36554

SANDOZ A/S

DK

DK/H/0963/002

1-26866

1A PHARMA GMBH

AT

DK/H/0960/002

1-26856

HEXAL PHARMA GMBH

AT

DK/H/0960/002

66344.00.00

HEXAL AG

DE

DK/H/0964/002

1-26875

SANDOZ GMBH

AT

UK/H/5127/006

027444025

PFIZER ITALIA S.R.L.

IT

UK/H/5127/005

027444013

PFIZER ITALIA S.R.L.

IT

UK/H/5127/006 not available UK/H/5127/005 not available UK/H/5127/006

PL 00057/1433 PL 30684/0224 PL 00057/1432 PL 30684/0223 PA 0019/055/002

PFIZER LIMITED DAWA LIMITED PFIZER LIMITED DAWA LIMITED PFIZER LIMITED

UK UK UK UK IE

not available

34009 382 351 2 8

FR

not available

34009 333 420 4 3

not available

34009 333 419 6 1

UK/H/5127/005

PA 0019/055/001

PFIZER HOLDING FRANCE (S.C.A.) PFIZER HOLDING FRANCE (S.C.A.) PFIZER HOLDING FRANCE (S.C.A.) PFIZER LIMITED

not available

34009 382 352 9 6

PFIZER HOLDING FRANCE (S.C.A.)

FR

List of nationally authorised medicinal products EMA/764352/2017

FR FR IE

Page 2/11

Product name in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

AMLODIPINE PFIZER 5 mg, gélule AMLODIPINE PFIZER 5 mg, gélule Amlohexal, tabletter Amlor 10 mg gélules Amlor 10 mg gélules Amlor 10 mg harde capsules Amlor 10 mg Hartkapseln Amlodipin Amlor 10 mg Hartkapseln Amlodipin AMLOR 10 mg, gélule

not available

34009 333 416 7 1

FR

not available

34009 333 417 3 2

DK/H/0960/002 UK/H/5127/004 UK/H/5127/004 UK/H/5127/004 UK/H/5127/004

36542 BE148303 2003127931 BE148303 BE148303

PFIZER HOLDING FRANCE (S.C.A.) PFIZER HOLDING FRANCE (S.C.A.) HEXAL A/S PFIZER S.A. (BELGIUM) PFIZER S.A. (BELGIUM) PFIZER S.A. (BELGIUM) PFIZER S.A. (BELGIUM)

UK/H/5127/004

2003127931

PFIZER S.A. (BELGIUM)

LU

UK/H/5127/004

34009 333 133 5 7

FR

AMLOR 10 mg, gélule

UK/H/5127/004

34009 372 438 8 9

Amlor 5 mg gélules Amlor 5 mg gélules Amlor 5 mg harde capsules Amlor 5 mg Hartkapseln Amlodipin Amlor 5 mg Hartkapseln Amlodipin AMLOR 5 mg, gélule

UK/H/5127/003 UK/H/5127/003 UK/H/5127/003 UK/H/5127/003

BE148041 2003127930 BE148041 BE148041

PFIZER HOLDING FRANCE (S.C.A.) PFIZER HOLDING FRANCE (S.C.A.) PFIZER S.A. (BELGIUM) PFIZER S.A. (BELGIUM) PFIZER S.A. (BELGIUM) PFIZER S.A. (BELGIUM)

UK/H/5127/003

2003127930

PFIZER S.A. (BELGIUM)

LU

UK/H/5127/003

34009 333 135 8 6

FR

AMLOR 5 mg, gélule

UK/H/5127/003

34009 557 706 9 5

AMLOR 5 mg, gélule

UK/H/5127/003

34009 372 437 1 1

Antacal 10 mg compresse

not available

027461021

Antacal 5 mg compresse

not available

027461019

Astudal 10 mg comprimidos Astudal 5 mg comprimidos

not available not available

59.162 59.161

PFIZER HOLDING FRANCE (S.C.A.) PFIZER HOLDING FRANCE (S.C.A.) PFIZER HOLDING FRANCE (S.C.A.) ERREKAPPA EUROTERAPICI SPA ERREKAPPA EUROTERAPICI SPA ALMIRALL, S.A. ALMIRALL, S.A.

List of nationally authorised medicinal products EMA/764352/2017

FR DK BE LU BE BE

FR BE LU BE BE

FR FR IT IT ES ES

Page 3/11

Product name in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Istin 10 mg hard capsules Istin 10 mg orodispersible tablets Istin 10 mg tablets Istin 10 mg tablets ISTIN 10 mg tablets Istin 5 mg hard capsules Istin 5 mg orodispersible tablets Istin 5 mg tablets Istin 5 mg tablets ISTIN 5 mg tablets Norvas 10 mg comprimidos Norvas 5 mg comprimidos Norvasc 10 mg capsule Norvasc 10 mg capsule Norvasc 10 mg capsule Norvasc 10 mg capsule Norvasc 10 mg capsule Norvasc 10 mg capsule Norvasc 10 mg capsule Norvasc 10 mg capsule Norvasc 10 mg capsule Norvasc 10 mg capsule Norvasc 10 mg compresse Norvasc 10 mg comprimate Norvasc 10 mg comprimate Norvasc 10 mg comprimate Norvasc 10 mg comprimate Norvasc 10 mg comprimate Norvasc 10 mg comprimate Norvasc 10 mg comprimate Norvasc 10 mg comprimate Norvasc 10 mg comprimate Norvasc 10 mg comprimate

UK/H/5127/004 UK/H/5123/002

PL 00057/1416 PL 00057/1390

PFIZER LIMITED PFIZER LIMITED

UK UK

UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/003 UK/H/5123/001

PA 19/45/2 MA505/03102 PL 00057/0298 PL 00057/1415 PL 00057/1389

PFIZER PFIZER PFIZER PFIZER PFIZER

IE MT UK UK UK

UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/002 UK/H/5127/001 UK/H/5127/004 UK/H/5127/004 UK/H/5127/004 UK/H/5127/004 UK/H/5127/004 UK/H/5127/004 UK/H/5127/004 UK/H/5127/004 UK/H/5127/004 UK/H/5127/004 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002

PA 19/45/1 MA505/03101 PL 00057/0297 59.160 59.159 5657/2013/02 5657/2013/05 5657/2013/04 5657/2013/09 5657/2013/07 5657/2013/08 5657/2013/03 5657/2013/06 5657/2013/10 5657/2013/01 027428022 5655/2013/07 5655/2013/13 5655/2013/08 5655/2013/10 5655/2013/04 5655/2013/14 5655/2013/11 5655/2013/17 5655/2013/06 5655/2013/15

PFIZER LIMITED PFIZER HELLAS, A.E. PFIZER LIMITED PFIZER, S.L. PFIZER, S.L. PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG PFIZER ITALIA S.R.L. PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG

List of nationally authorised medicinal products EMA/764352/2017

LIMITED HELLAS, A.E. LIMITED LIMITED LIMITED

IE MT UK ES ES RO RO RO RO RO RO RO RO RO RO IT RO RO RO RO RO RO RO RO RO RO

Page 4/11

Product name in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc

comprimate comprimate comprimate comprimate comprimate comprimate comprimate comprimidos

UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002

5655/2013/16 5655/2013/09 5655/2013/03 5655/2013/02 5655/2013/05 5655/2013/12 5655/2013/01 8793026

MA EEIG MA EEIG MA EEIG MA EEIG MA EEIG MA EEIG MA EEIG PFIZER,

RO RO RO RO RO RO RO PT

Norvasc 10 mg comprimidos

UK/H/5127/002

5829486

PFIZER,

PT

Norvasc 10 mg comprimidos orodispersíveis Norvasc 10 mg kietosios kapsulės Norvasc 10 mg kietosios kapsulės Norvasc 10 mg kietosios kapsulės Norvasc 10 mg kietosios kapsulės Norvasc 10 mg kietosios kapsulės Norvasc 10 mg kietosios kapsulės Norvasc 10 mg kietosios kapsulės Norvasc 10 mg kietosios kapsulės Norvasc 10 mg kietosios kapsulės Norvasc 10 mg kietosios kapsulės NORVASC 10 mg tablete Norvasc 10 mg tablete

UK/H/5123/002

5575816

PFIZER,

PT

UK/H/5127/004

LT/1/96/1466/045

PFIZER EUROPE PFIZER EUROPE PFIZER EUROPE PFIZER EUROPE PFIZER EUROPE PFIZER EUROPE PFIZER EUROPE LABORATÓRIOS LDA. LABORATÓRIOS LDA. LABORATÓRIOS LDA. PFIZER EUROPE

MA EEIG

LT

UK/H/5127/004

LT/1/96/1466/048

PFIZER EUROPE MA EEIG

LT

UK/H/5127/004

LT/1/96/1466/006

PFIZER EUROPE MA EEIG

LT

UK/H/5127/004

LT/1/96/1466/046

PFIZER EUROPE MA EEIG

LT

UK/H/5127/004

LT/1/96/1466/049

PFIZER EUROPE MA EEIG

LT

UK/H/5127/004

LT/1/96/1466/047

PFIZER EUROPE MA EEIG

LT

UK/H/5127/004

LT/1/96/1466/008

PFIZER EUROPE MA EEIG

LT

UK/H/5127/004

LT/1/96/1466/052

PFIZER EUROPE MA EEIG

LT

UK/H/5127/004

LT/1/96/1466/050

PFIZER EUROPE MA EEIG

LT

UK/H/5127/004

LT/1/96/1466/051

PFIZER EUROPE MA EEIG

LT

not available UK/H/5127/002

UP/I-530-09/12-02/392 H/99/01131/022

PFIZER CROATIA D.O.O. PFIZER LUXEMBOURG SARL

HR SI

10 10 10 10 10 10 10 10

mg mg mg mg mg mg mg mg

List of nationally authorised medicinal products EMA/764352/2017

Page 5/11

Product name in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Norvasc 10 mg tablete Norvasc 10 mg tablete Norvasc 10 mg tablete Norvasc 10 mg tablete Norvasc 10 mg tablete Norvasc 10 mg tablete Norvasc 10 mg tablete Norvasc 10 mg tablete Norvasc 10 mg tablete Norvasc 10 mg tablete Norvasc 10 mg tablete Norvasc 10 mg tablete Norvasc 10 mg tablete Norvasc 10 mg tablete Norvasc 10 mg tablete Norvasc 10 mg tablete Norvasc 10 mg tabletes Norvasc 10 mg tabletės Norvasc 10 mg tabletės Norvasc 10 mg tabletės Norvasc 10 mg tabletės Norvasc 10 mg tabletės Norvasc 10 mg tabletės Norvasc 10 mg tabletės Norvasc 10 mg tabletės Norvasc 10 mg tabletės Norvasc 10 mg tabletės Norvasc 10 mg tabletės Norvasc 10 mg tabletės Norvasc 10 mg tabletės Norvasc 10 mg tabletės Norvasc 10 mg tabletės Norvasc 10 mg tabletės Norvasc 10 mg tabletės NORVASC 10 mg tabletit

UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002

H/99/01131/024 H/99/01131/026 H/99/01131/028 H/99/01131/018 H/99/01131/032 H/99/01131/020 H/99/01131/023 H/99/01131/021 H/99/01131/017 H/99/01131/025 H/99/01131/019 H/99/01131/029 H/99/01131/027 H/99/01131/031 H/99/01131/033 H/99/01131/030 97-0601 LT/1/96/1466/054 LT/1/96/1466/033 LT/1/96/1466/026 LT/1/96/1466/035 LT/1/96/1466/034 LT/1/96/1466/028 LT/1/96/1466/024 LT/1/96/1466/027 LT/1/96/1466/036 LT/1/96/1466/030 LT/1/96/1466/032 LT/1/96/1466/004 LT/1/96/1466/025 LT/1/96/1466/029 LT/1/96/1466/023 LT/1/96/1466/022 LT/1/96/1466/031 10252

PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER

SI SI SI SI SI SI SI SI SI SI SI SI SI SI SI SI LV LT LT LT LT LT LT LT LT LT LT LT LT LT LT LT LT LT FI

List of nationally authorised medicinal products EMA/764352/2017

LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LIMITED EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG OY

Page 6/11

Product name in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc σκληρά Norvasc σκληρά Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc Norvasc

tabletta tabletter tabletter tabletter tablety töflur καψάκια

UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/002 UK/H/5127/004

OGYI-T-1934/02 10252 7527 11288 83/0437/12–S 880133 (IS) 13775

PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER

HU FI NO SE SK IS CY

10 mg καψάκια

UK/H/5127/004

26173/20-3-2014

PFIZER HELLAS, A.E.

GR

10, tabletten 10 mg 5 mg capsule 5 mg capsule 5 mg capsule 5 mg capsule 5 mg capsule 5 mg capsule 5 mg capsule 5 mg capsule 5 mg capsule 5 mg capsule 5 mg capsule 5 mg compresse 5 mg comprimate 5 mg comprimate 5 mg comprimate 5 mg comprimate 5 mg comprimate 5 mg comprimate 5 mg comprimate 5 mg comprimate 5 mg comprimate 5 mg comprimate 5 mg comprimate 5 mg comprimate

UK/H/5127/002 UK/H/5127/003 UK/H/5127/003 UK/H/5127/003 UK/H/5127/003 UK/H/5127/003 UK/H/5127/003 UK/H/5127/003 UK/H/5127/003 UK/H/5127/003 UK/H/5127/003 UK/H/5127/003 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001

RVG 13349 5656/2013/02 5656/2013/04 5656/2013/05 5656/2013/03 5656/2013/06 5656/2013/07 5656/2013/10 5656/2013/09 5656/2013/08 5656/2013/11 5656/2013/01 027428010 5654/2013/08 5654/2013/14 5654/2013/12 5654/2013/15 5654/2013/09 5654/2013/05 5654/2013/06 5654/2013/02 5654/2013/11 5654/2013/03 5654/2013/10 5654/2013/04

PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER

NL RO RO RO RO RO RO RO RO RO RO RO IT RO RO RO RO RO RO RO RO RO RO RO RO

10 10 10 10 10 10 10

mg mg mg mg mg mg mg

List of nationally authorised medicinal products EMA/764352/2017

KFT. OY AS AB EUROPE MA EEIG APS HELLAS, A.E.

B.V. EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG ITALIA S.R.L. EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG

Page 7/11

Product name in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Norvasc Norvasc Norvasc Norvasc Norvasc

comprimate comprimate comprimate comprimate comprimidos

UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001

5654/2013/16 5654/2013/13 5654/2013/07 5654/2013/01 8793000

MA EEIG MA EEIG MA EEIG MA EEIG PFIZER,

RO RO RO RO PT

Norvasc 5 mg comprimidos

UK/H/5127/001

8793018

PFIZER,

PT

Norvasc 5 mg comprimidos

UK/H/5127/001

5828884

PFIZER,

PT

Norvasc 5 mg comprimidos

UK/H/5127/001

5829585

PFIZER,

PT

Norvasc 5 mg comprimidos orodispersíveis Norvasc 5 mg comprimidos orodispersíveis Norvasc 5 mg kietosios kapsulės Norvasc 5 mg kietosios kapsulės Norvasc 5 mg kietosios kapsulės Norvasc 5 mg kietosios kapsulės Norvasc 5 mg kietosios kapsulės Norvasc 5 mg kietosios kapsulės Norvasc 5 mg kietosios kapsulės Norvasc 5 mg kietosios kapsulės Norvasc 5 mg kietosios kapsulės

UK/H/5123/001

5575618

PFIZER,

PT

UK/H/5123/001

5575600

PFIZER,

PT

UK/H/5127/003

LT/1/96/1466/053

PFIZER EUROPE PFIZER EUROPE PFIZER EUROPE PFIZER EUROPE LABORATÓRIOS LDA. LABORATÓRIOS LDA. LABORATÓRIOS LDA. LABORATÓRIOS LDA. LABORATÓRIOS LDA. LABORATÓRIOS LDA. PFIZER EUROPE

MA EEIG

LT

UK/H/5127/003

LT/1/96/1466/039

PFIZER EUROPE MA EEIG

LT

UK/H/5127/003

LT/1/96/1466/037

PFIZER EUROPE MA EEIG

LT

UK/H/5127/003

LT/1/96/1466/038

PFIZER EUROPE MA EEIG

LT

UK/H/5127/003

LT/1/96/1466/042

PFIZER EUROPE MA EEIG

LT

UK/H/5127/003

LT/1/96/1466/044

PFIZER EUROPE MA EEIG

LT

UK/H/5127/003

LT/1/96/1466/043

PFIZER EUROPE MA EEIG

LT

UK/H/5127/003

LT/1/96/1466/041

PFIZER EUROPE MA EEIG

LT

UK/H/5127/003

LT/1/96/1466/040

PFIZER EUROPE MA EEIG

LT

5 5 5 5 5

mg mg mg mg mg

List of nationally authorised medicinal products EMA/764352/2017

Page 8/11

Product name in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Norvasc 5 kapsulės Norvasc 5 kapsulės NORVASC Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5 Norvasc 5

mg kietosios

UK/H/5127/003

LT/1/96/1466/007

PFIZER EUROPE MA EEIG

LT

mg kietosios

UK/H/5127/003

LT/1/96/1466/005

PFIZER EUROPE MA EEIG

LT

5 mg tablete mg tablete mg tablete mg tablete mg tablete mg tablete mg tablete mg tablete mg tablete mg tablete mg tablete mg tablete mg tablete mg tablete mg tablete mg tablete mg tablete mg tabletes mg tabletės mg tabletės mg tabletės mg tabletės mg tabletės mg tabletės mg tabletės mg tabletės mg tabletės mg tabletės mg tabletės mg tabletės mg tabletės

not available UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001

UP/I-530-09/12-02/391 H/99/01131/002 H/99/01131/008 H/99/01131/014 H/99/01131/015 H/99/01131/004 H/99/01131/009 H/99/01131/016 H/99/01131/010 H/99/01131/013 H/99/01131/005 H/99/01131/007 H/99/01131/011 H/99/01131/003 H/99/01131/012 H/99/01131/006 H/99/01131/001 97-0600 LT/1/96/1466/016 LT/1/96/1466/020 LT/1/96/1466/015 LT/1/96/1466/013 LT/1/96/1466/009 LT/1/96/1466/018 LT/1/96/1466/011 LT/1/96/1466/014 LT/1/96/1466/003 LT/1/96/1466/021 LT/1/96/1466/001 LT/1/96/1466/019 LT/1/96/1466/010

PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER

HR SI SI SI SI SI SI SI SI SI SI SI SI SI SI SI SI LV LT LT LT LT LT LT LT LT LT LT LT LT LT

List of nationally authorised medicinal products EMA/764352/2017

CROATIA D.O.O. LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LUXEMBOURG SARL LIMITED EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG

Page 9/11

Product name in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Norvasc 5 mg tabletės Norvasc 5 mg tabletės Norvasc 5 mg tabletės NORVASC 5 mg tabletit Norvasc 5 mg tabletta Norvasc 5 mg tabletter Norvasc 5 mg tabletter Norvasc 5 mg tabletter Norvasc 5 mg tablety Norvasc 5 mg töflur Norvasc 5 mg καψάκια σκληρά Norvasc 5 mg καψάκια σκληρά Norvasc 5, tabletten 5 mg NORVASC, 10 mg tabletid Norvasc, 10 mg, tabletki NORVASC, 5 mg tabletid Norvasc, 5 mg, tabletki Norvasc, tabletter Norvasc, tabletter Norvasc® 10 mg Tabletten

UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/001 UK/H/5127/003

LT/1/96/1466/002 LT/1/96/1466/017 LT/1/96/1466/012 10251 OGYI-T-1934/01 10251 7526 11287 83/0871/92–C/S 880134 (IS) 13774

PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER PFIZER

LT LT LT FI HU FI NO SE SK IS CY

UK/H/5127/003

26172/20-3-2014

PFIZER HELLAS, A.E.

GR

UK/H/5127/001 UK/H/5127/002 UK/H/5127/002 UK/H/5127/001 UK/H/5127/001 UK/H/5127/002 UK/H/5127/001 UK/H/5127/002

RVG 13348 176397 R/0129 176297 R/0128 13335 13334 1-19248

NL EE PL EE PL DK DK AT

Norvasc® 10 mg Tabletten Norvasc® 5 mg Tabletten

UK/H/5127/002 UK/H/5127/001

16909.01.00 1-19247

Norvasc® 5 mg Tabletten ZOREM 10 mg tablety ZOREM 5 mg tablety Норваск 10 mg таблетки Норваск 5 mg таблетки

UK/H/5127/001 UK/H/5127/006 UK/H/5127/005 UK/H/5127/002 UK/H/5127/001

16909.00.00 83/375/01-C 83/374/01-C 20000436 20000435

PFIZER B.V. PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG PFIZER APS PFIZER APS PFIZER CORPORATION AUSTRIA GESELLSCHAFT M.B.H. PFIZER PHARMA PFE GMBH PFIZER CORPORATION AUSTRIA GESELLSCHAFT M.B.H. PFIZER PHARMA PFE GMBH PFIZER, SPOL. S R.O. PFIZER, SPOL. S R.O. PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG

List of nationally authorised medicinal products EMA/764352/2017

EUROPE MA EEIG EUROPE MA EEIG EUROPE MA EEIG OY KFT. OY AS AB EUROPE MA EEIG APS HELLAS, A.E.

DE AT DE CZ CZ BG BG

Page 10/11

List of nationally authorised medicinal products EMA/764352/2017

Page 11/11

PSUSA/00000174/201703 - European Medicines Agency - Europa EU

European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged. 11 October 2017. EMA/764352/2017. Human Medicines Evaluation Division. List of nationally authorised medicinal products. Active substance(s): amlodipine. Procedure No.: PSUSA/00000174/201703 ...

185KB Sizes 27 Downloads 254 Views

Recommend Documents

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Eleclazine - European Medicines Agency - Europa EU
Feb 9, 2017 - Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply).

July 2017 - European Medicines Agency - Europa EU
Jul 5, 2017 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

SME Office - European Medicines Agency - Europa EU
maximises the chances of a successful marketing authorisation. ... marketing authorisation. • inclusion in the public SME ... E-mail [email protected]. Website ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Action plan - European Medicines Agency - Europa EU
5 days ago - Guidelines should include more details on the principles of good information design in which content and layout are ... relevance and importance of the QRD template is also acknowledged in this respect as it is the main tool .... databas

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - Add an existing Tag to a specific Term . ...... This service creates an email body (text/html) of a user's notification data, a notification is based on.

ATMP - European Medicines Agency - Europa EU
Nov 24, 2017 - E8. 09/08/2017. 10/08/2017. 24/08/2017 17/08/2017 22/08/2017. 24/08/2017. 30/08/2017. 01/09/2017. 04/09/2017. 08/09/2017. 14/09/2017.

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Evofosfamide - European Medicines Agency - Europa EU
Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply). (possible) lack of ...

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

minoxidil - European Medicines Agency - Europa EU
Jun 14, 2018 - Page 2/26. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the.

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för

latanoprost - European Medicines Agency - Europa EU
May 13, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ..... Xaloptic Free. NL/H/3193/001.

Cyproterone/ethinylestradiol - European Medicines Agency - Europa EU
March 2016 a joint database drug utilisation final study report to the European .... With regards to prescription of CPA/EE for contraceptive management, ...

ganciclovir - European Medicines Agency - Europa EU
Feb 9, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. 20010180.

July 2016 - European Medicines Agency - Europa EU
For a list of RSS readers please refer to our RSS guide and follow the instructions ..... PCWP and HCPWP joint meeting: Workshop on social media - Sep 2016.

Stem cell - European Medicines Agency - Europa EU
Jul 14, 2016 - Stem cell-based products for veterinary use: specific ... potentially delay time to rejection providing a window of therapeutic benefit but limiting ...